Status:
UNKNOWN
incidenCe and predictOrs of heaRt fAiLure After Acute coronarY Syndrome: CORALYS
Lead Sponsor:
A.O.U. Città della Salute e della Scienza
Collaborating Sponsors:
University of Turin, Italy
Conditions:
Acute Coronary Syndrome
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Single-cohort retrospective study evaluating the incidence and prognostic markers of heart failure following acute coronary syndrome treated by percutaneous coronary intervention
Detailed Description
Acute coronary syndrome (ACS) is the most common cause of heart failure (HF) world-wide. Primary percutaneous coronary intervention (PCI) has deeply improved short and long-term survival after ACS, bu...
Eligibility Criteria
Inclusion
- • Informed consent
- Age ≥ 18 years
- Previous acute coronary syndrome with percutaneous coronary revascularization
- Baseline EF \> 40%
- At least 12 months of follow-up
Exclusion
- • Significant valvular heart disease (greater than mild stenosis or moderate regurgitation) before ACS
- Type 1, 3, 4, 5 pulmonary hypertension (14) before ACS
- Constrictive pericarditis before ACS
- Primary or infiltrative cardiomyopathies
- Heart transplantation
- Medical therapy with loop diuretics for heart failure before ACS
- Previous hospitalizations for heart failure or clinical sign of heart failure detected outpatient before ACS
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04895176
Start Date
June 1 2021
End Date
June 30 2021
Last Update
May 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Città della Salute e della Scienza di Torino
Torino, Italy, 10126